Industry Developments

BMI Core View: Corporate social responsibility (CSR) is an underappreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled... 2012-01-05

BMI View: Multinational drug companies and medical device makers can benefit from the Brazilian government's promotion of the local industry by collaborating with local companies to... 2012-01-04

BMI View: The new Argentine pharmaceutical depot, to be constructed by Marken, will benefit local and international pharmaceutical companies. BMI believes Argentina is attractive to... 2011-12-23

BMI View: Plans by the Venezuelan government to build pharmaceutical plants are unlikely to lower medicine costs for patients due to the inherent inefficiency of state-backed drugmakers... 2011-12-22

BMI View: Despite strong underlying fundamentals, Brazil's pharmaceutical market growth rate is expected to slow due to concerns over the country's long-term fiscal policy and, to a... 2011-12-21

BMI View: Pharmaceutical companies will benefit from the growth in the number of doctors in Canada due to the potential increase in prescriptions and consumers' preference for patented... 2011-12-20

BMI View: The launch of a health insurance exchange in the US Virgin Islands has the potential to provide insurance companies with opportunities to collaborate with the government,... 2011-12-19

BMI View: Governments, companies and investors could potentially acquire high-standard drugs and medical services at very reasonable prices from Cuba. However, few will be actually... 2011-12-16

BMI View: Multinational pharmaceutical companies will open more manufacturing facilities in Foreign Trade Zones (FTZs) in Puerto Rico to benefit from the low tax rate and below-average... 2011-12-15

BMI View: New hospitals in Ecuador will fulfil unmet medical needs and bring new opportunities for pharmaceutical companies, medical equipment suppliers and other investors in the medical... 2011-12-13